Nu Skin Enterprises 将来の成長

NYSE:NUS - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	1,765	N/A	N/A	N/A	1
12/31/2025	1,747	49	46	116	3
12/31/2024	1,728	-110	24	102	3
9/30/2024	1,775	-103	91	140	N/A
6/30/2024	1,844	-148	107	160	N/A
3/31/2024	1,905	-3	85	144	N/A
12/31/2023	1,969	9	60	119	N/A
9/30/2023	2,003	59	38	90	N/A
6/30/2023	2,042	70	2	67	N/A
3/31/2023	2,102	77	18	78	N/A
12/31/2022	2,226	105	49	108	N/A
9/30/2022	2,377	38	129	192	N/A
6/30/2022	2,480	113	142	194	N/A
3/31/2022	2,624	139	108	168	N/A
12/31/2021	2,696	147	73	142	N/A
9/30/2021	2,770	230	61	127	N/A
6/30/2021	2,833	237	143	215	N/A
3/31/2021	2,741	219	227	291	N/A
12/31/2020	2,582	191	315	379	N/A
9/30/2020	2,417	158	272	334	N/A
6/30/2020	2,304	146	204	270	N/A
3/31/2020	2,315	150	183	255	N/A
12/31/2019	2,420	174	112	178	N/A
9/30/2019	2,520	116	136	217	N/A
6/30/2019	2,606	125	154	225	N/A
3/31/2019	2,686	129	124	196	N/A
12/31/2018	2,679	122	132	203	N/A
9/30/2018	2,662	158	197	261	N/A
6/30/2018	2,550	146	N/A	270	N/A
3/31/2018	2,396	137	N/A	280	N/A
12/31/2017	2,279	129	N/A	303	N/A
9/30/2017	2,144	149	N/A	246	N/A
6/30/2017	2,185	165	N/A	223	N/A
3/31/2017	2,235	167	N/A	299	N/A
12/31/2016	2,208	143	N/A	275	N/A
9/30/2016	2,249	141	N/A	266	N/A
6/30/2016	2,216	100	N/A	298	N/A
3/31/2016	2,176	100	N/A	245	N/A
12/31/2015	2,247	133	N/A	322	N/A
9/30/2015	2,284	144	N/A	337	N/A
6/30/2015	2,352	196	N/A	288	N/A
3/31/2015	2,442	171	N/A	178	N/A
12/31/2014	2,569	189	N/A	-56	N/A
9/30/2014	3,016	268	N/A	-105	N/A
6/30/2014	3,285	311	N/A	156	N/A
3/31/2014	3,306	365	N/A	299	N/A
12/31/2013	3,177	365	N/A	530	N/A

アナリストによる今後の成長予測

収入対貯蓄率: NUSは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.6% ) よりも高い成長率であると考えられます。

収益対市場: NUS今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: NUS今後 3 年以内に収益を上げることが予想されます。

収益対市場: NUSの収益は今後 3 年間で減少すると予想されています (年間-0.06% )。

高い収益成長: NUSの収益は今後 3 年間で減少すると予測されています (年間-0.06% )。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: NUSの自己資本利益率は、3年後には低くなると予測されています ( 8.8 %)。

Nu Skin Enterprises 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024 and Adjusts Earnings Guidance for the Year 2024

Nu Skin Enterprises, Inc. Revises Financial Guidance for the Full Year of 2024

Price target decreased by 11% to US$12.83

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Price target decreased by 11% to US$13.83

Consensus revenue estimates fall by 11%

Recent updates

Upcoming dividend of US$0.06 per share

Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation

Third quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on December 11, 2024

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024 and Adjusts Earnings Guidance for the Year 2024

Nu Skin Introduces MYND360™, a New Line of Clinically Proven Supplements and Topicals for Mental Well-Being

Nu Skin Enterprises, Inc. to Report Q3, 2024 Results on Nov 07, 2024

The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Nu Skin Enterprises Appoints Mark A. Zorko to its Board of Directors and Audit Committee and Nominating and Corporate Governance Committee

Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Upcoming dividend of US$0.06 per share

Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Second quarter dividend of US$0.06 announced

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Nu Skin Enterprises, Inc. Revises Financial Guidance for the Full Year of 2024

Nu Skin Enterprises, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Insufficient new directors

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Upcoming dividend of US$0.06 per share

Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

First quarter dividend of US$0.06 announced

Price target decreased by 11% to US$12.83

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Price target decreased by 11% to US$13.83

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on June 12, 2024

Now 23% undervalued after recent price drop

Nu Skin Enterprises, Inc., Annual General Meeting, Jun 05, 2024

Now 21% undervalued after recent price drop

Nu Skin Enterprises, Inc. to Report Q1, 2024 Results on May 08, 2024

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Consensus revenue estimates fall by 11%

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Price target decreased by 26% to US$15.50

Fourth quarter dividend reduced to US$0.06

Full year 2023 earnings: EPS misses analyst expectations

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024

Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Consensus EPS estimates fall by 31%

Nu Skin Enterprises, Inc. to Report Q4, 2023 Results on Feb 14, 2024

Consensus EPS estimates fall by 32%

Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Upcoming dividend of US$0.39 per share at 8.8% yield

Independent Director recently sold US$272k worth of stock

Independent Director notifies of intention to sell stock

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on December 6, 2023

Price target decreased by 12% to US$27.75

Nu Skin: Is It Just A Growth Problem?

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Nu Skin Enterprises, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Independent Director notifies of intention to sell stock

When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Independent Director recently sold US$146k worth of stock

Upcoming dividend of US$0.39 per share at 6.4% yield

Now 21% undervalued after recent price drop

Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Price target decreased by 22% to US$31.50

Nu Skin Enterprises, Inc. Provides Earnings Outlook for the Third Quarter and Full-Year 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind